Ieq Capital LLC Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ieq Capital LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,827 shares of the medical equipment provider's stock after selling 8,173 shares during the period. Ieq Capital LLC's holdings in Intuitive Surgical were worth $11,393,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management grew its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC grew its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several analyst reports. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Citigroup increased their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Finally, Evercore ISI increased their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $14.78 during midday trading on Friday, hitting $591.79. The company's stock had a trading volume of 1,673,828 shares, compared to its average volume of 1,567,754. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm's 50 day moving average is $565.45 and its 200-day moving average is $525.06. The firm has a market cap of $210.78 billion, a P/E ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.